David Almeida, MD, MBA, PhD, reviews the objectives and design of the TRUCKEE study, and discusses the visual and anatomic outcomes after one and three injections of faricimab in neovascular AMD.
The TRUCKEE Study: Real-World Efficacy and Safety of Faricimab in Neovascular AMD
Dr David Almeida shares two cases of neovascular AMD from his practice, one treatment-naïve and one previously treated, and presents his findings after switching them to faricimab.
Advertisement
Advertisement
Trending on Modern Retina
1
Retinoblastoma: Decreasing mortality, morbidity, and enucleation
2
Sydnexis receives CRL from the FDA for its SYD-101 pediatric myopia drug
3
AAO 2025: Trial findings apply gildeuretinol to treat moderate severity Stargardt disease
4
